创业板综合指数(399102.SZ)
Search documents
更全面的创业板投资标尺
量化藏经阁· 2025-12-04 00:08
Group 1 - The article emphasizes the balanced layout of A-share innovative and growth-oriented companies, focusing on the "Three Innovations and Four New" positioning of the ChiNext board, which has seen a steady increase in the number of listed companies since its inception, reaching 1,390 stocks with a total market value of 16.49 trillion RMB as of November 21, 2025, and an average daily trading volume of 523 billion RMB in the past month [1][3][41] - Continuous policy support is highlighted, with a significant number of "specialized, refined, characteristic, and innovative" small giant companies, totaling 1,117, of which 420 are listed on the ChiNext, accounting for 37.60% of the total [1][10][41] - Institutional funds show high interest, with the total market value of ChiNext component stocks held by actively managed equity funds showing an upward trend, exceeding 17% in recent years, and ChiNext-related ETFs have seen substantial growth, with the latest share exceeding 800 million and total scale surpassing 170 billion RMB [1][14][15][41] Group 2 - The ChiNext Composite Index (399102.SZ) encompasses all stocks listed on the ChiNext, reflecting the overall price changes and market trends, with a smaller average market capitalization of 13.034 billion RMB compared to the ChiNext Index and ChiNext 50 [19][22][42] - The industry concentration is low, with a more balanced allocation across high-growth innovative sectors, including new energy, electronics, pharmaceuticals, and computing, compared to the more concentrated distribution in the ChiNext 50 and ChiNext Index [26][42] - Valuation is at a low level, with a price-to-earnings ratio of 62.64 and a price-to-book ratio of 4.04, both below historical median levels, and a forecasted compound annual growth rate of net profit of 39.92% over the next two years, outperforming the ChiNext Index and ChiNext 50 [30][33][42] - The risk-return profile of the ChiNext Composite Index is notable, with an annualized return of 8.99% since the base period and a Sharpe ratio of 0.44, indicating superior performance and risk characteristics compared to the ChiNext Index and ChiNext 50 [38][42]
金融工程专题研究:创业板综合指数投资价值分析:更全面的创业板投资标尺
Guoxin Securities· 2025-11-28 13:56
Group 1 - The report emphasizes the positioning of the ChiNext board as focusing on "three innovations and four new" initiatives, supporting innovative and high-growth SMEs since its inception, with a total of 1,390 listed stocks and a market capitalization of 16.49 trillion RMB as of November 21, 2025 [10][12][51] - Continuous policy support has led to a high concentration of specialized and innovative "little giant" companies, with 1,117 such companies listed, of which 420 are on the ChiNext board, accounting for 37.60% of the total [20][51] - Institutional funds have shown high interest, with the total market value of actively managed equity funds holding ChiNext component stocks increasing, maintaining a share of over 17% in recent years [24][51] Group 2 - The ChiNext Composite Index (399102.SZ) encompasses all stocks listed on the ChiNext board, reflecting the overall price changes and market trends [52] - The average market capitalization of the ChiNext Composite Index is 13.034 billion RMB, significantly lower than that of the ChiNext Index and ChiNext 50, with 26.44% of its component stocks having a market cap of less than 10 billion RMB [31][52] - The industry concentration of the ChiNext Composite Index is low, with a balanced allocation across high-growth sectors such as new energy, electronics, pharmaceuticals, and computing [34][52] Group 3 - The valuation of the ChiNext Composite Index is at a low level, with a price-to-earnings ratio of 62.64 and a price-to-book ratio of 4.04, both below historical median levels [38][52] - The expected compound annual growth rate of net profit for the ChiNext Composite Index over the next two years is 39.92%, outperforming the ChiNext Index and ChiNext 50 [40][52] - The index has a strong risk-return profile, with an annualized return of 8.99% and a Sharpe ratio of 0.44, indicating a favorable risk-return balance compared to the ChiNext Index and ChiNext 50 [45][53]